Immediate versus delayed versus no antibiotics for respiratory infections - PubMed (original) (raw)

Review

Immediate versus delayed versus no antibiotics for respiratory infections

Geoffrey Kp Spurling et al. Cochrane Database Syst Rev. 2023.

Abstract

Background: Concerns exist regarding antibiotic prescribing for respiratory tract infections (RTIs) owing to adverse reactions, cost and antibacterial resistance. One proposed strategy to reduce antibiotic prescribing is to provide prescriptions, but to advise delay in antibiotic use with the expectation that symptoms will resolve first. This is an update of a Cochrane Review originally published in 2007, and updated in 2010, 2013 and 2017.

Objectives: To evaluate the effects on duration and/or severity of clinical outcomes (pain, malaise, fever, cough and rhinorrhoea), antibiotic use, antibiotic resistance and patient satisfaction of advising a delayed prescription of antibiotics in respiratory tract infections.

Search methods: From May 2017 until 20 August 2022, this was a living systematic review with monthly searches of the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, Embase, CINAHL and Web of Science. We also searched the WHO International Clinical Trials Registry Platform (ICTRP) and ClinicalTrials.gov on 20 August 2022. Due to the abundance of evidence supporting the review's key findings, it ceased being a living systematic review on 21 August 2022.

Selection criteria: Randomised controlled trials involving participants of all ages with an RTI, where delayed antibiotics were compared to immediate or no antibiotics. We defined a delayed antibiotic as advice to delay the filling of an antibiotic prescription by at least 48 hours. We considered all RTIs regardless of whether antibiotics were recommended or not.

Data collection and analysis: We used standard Cochrane methodological procedures.

Main results: For this 2022 update, we added one new trial enrolling 448 children (436 analysed) with uncomplicated acute RTIs. Overall, this review includes 12 studies with a total of 3968 participants, of which data from 3750 are available for analysis. These 12 studies involved acute RTIs including acute otitis media (three studies), streptococcal pharyngitis (three studies), cough (two studies), sore throat (one study), common cold (one study) and a variety of RTIs (two studies). Six studies involved only children, two only adults and four included both adults and children. Six studies were conducted in primary care, four in paediatric clinics and two in emergency departments. Studies were well reported and appeared to provide moderate-certainty evidence. Randomisation was not adequately described in two trials. Four trials blinded the outcome assessor, and three included blinding of participants and doctors. We conducted meta-analyses for pain, malaise, fever, adverse effects, antibiotic use and patient satisfaction. Cough (four studies): we found no differences amongst delayed, immediate and no prescribed antibiotics for clinical outcomes in any of the four studies. Sore throat (six studies): for the outcome of fever with sore throat, four of the six studies favoured immediate antibiotics, and two found no difference. For the outcome of pain related to sore throat, two studies favoured immediate antibiotics, and four found no difference. Two studies compared delayed antibiotics with no antibiotic for sore throat, and found no difference in clinical outcomes. Acute otitis media (four studies): two studies compared immediate with delayed antibiotics - one found no difference for fever, and the other favoured immediate antibiotics for pain and malaise severity on Day 3. Two studies compared delayed with no antibiotics: one found no difference for pain and fever severity on Day 3, and the other found no difference for the number of children with fever on Day 3. Common cold (two studies): neither study found differences for clinical outcomes between delayed and immediate antibiotic groups. One study found delayed antibiotics were probably favoured over no antibiotics for pain, fever and cough duration (moderate-certainty evidence).

Adverse effects: there were either no differences for adverse effects or results may have favoured delayed over immediate antibiotics with no significant differences in complication rates (low-certainty evidence). Antibiotic use: delayed antibiotics probably resulted in a reduction in antibiotic use compared to immediate antibiotics (odds ratio (OR) 0.03, 95% confidence interval (CI) 0.01 to 0.07; 8 studies, 2257 participants; moderate-certainty evidence). However, a delayed antibiotic was probably more likely to result in reported antibiotic use than no antibiotics (OR 2.52, 95% CI 1.69 to 3.75; 5 studies, 1529 participants; moderate-certainty evidence). Patient satisfaction: patient satisfaction probably favoured delayed over no antibiotics (OR 1.45, 1.08 to 1.96; 5 studies, 1523 participants; moderate-certainty evidence). There was probably no difference in patient satisfaction between delayed and immediate antibiotics (OR 0.77, 95% CI 0.45 to 1.29; 7 studies, 1927 participants; moderate-certainty evidence). No studies evaluated antibiotic resistance. Reconsultation rates and use of alternative medicines were similar for delayed, immediate and no antibiotic strategies. In one of the four studies reporting use of alternative medicines, less paracetamol was used in the immediate group compared to the delayed group.

Authors' conclusions: For many clinical outcomes, there were no differences between prescribing strategies. Symptoms for acute otitis media and sore throat were modestly improved by immediate antibiotics compared with delayed antibiotics. There were no differences in complication rates. Delaying prescribing did not result in significantly different levels of patient satisfaction compared with immediate provision of antibiotics (86% versus 91%; moderate-certainty evidence). However, delay was favoured over no antibiotics (87% versus 82%). Delayed antibiotics achieved lower rates of antibiotic use compared to immediate antibiotics (30% versus 93%). The strategy of no antibiotics further reduced antibiotic use compared to delaying prescription for antibiotics (13% versus 27%). Delayed antibiotics for people with acute respiratory infection reduced antibiotic use compared to immediate antibiotics, but was not shown to be different to no antibiotics in terms of symptom control and disease complications. Where clinicians feel it is safe not to prescribe antibiotics immediately for people with RTIs, no antibiotics with advice to return if symptoms do not resolve is likely to result in the least antibiotic use while maintaining similar patient satisfaction and clinical outcomes to delayed antibiotics. Where clinicians are not confident in not prescribing antibiotics, delayed antibiotics may be an acceptable compromise in place of immediate prescribing to significantly reduce unnecessary antibiotic use for RTIs, while maintaining patient safety and satisfaction levels. Further research into antibiotic prescribing strategies for RTIs may best be focused on identifying patient groups at high risk of disease complications, enhancing doctors' communication with patients to maintain satisfaction, ways of increasing doctors' confidence to not prescribe antibiotics for RTIs, and policy measures to reduce unnecessary antibiotic prescribing for RTIs.

Copyright © 2023 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

PubMed Disclaimer

Conflict of interest statement

Geoffrey KP Spurling has declared that they have no conflict of interest. Liz Dooley has declared that they have no conflict of interest. Deborah A Askew has declared that they have no conflict of interest. Justin Clark has declared that he has no conflict of interest.

Figures

1

1

Study flow diagram.

2

2

Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.

3

3

Risk of bias summary: review authors' judgements about each risk of bias item for each included study.

1.1

1.1. Analysis

Comparison 1: Pain, Outcome 1: Number of participants with pain on days 3 to 6: delayed versus immediate antibiotics

1.2

1.2. Analysis

Comparison 1: Pain, Outcome 2: Pain severity on day 3: delayed versus immediate antibiotics

1.3

1.3. Analysis

Comparison 1: Pain, Outcome 3: Duration of pain: delayed versus immediate antibiotics (days)

1.4

1.4. Analysis

Comparison 1: Pain, Outcome 4: Duration of pain: delayed versus no antibiotics (days)

2.1

2.1. Analysis

Comparison 2: Malaise, Outcome 1: Number of participants with malaise on days 3 to 6: delayed versus immediate antibiotics

2.2

2.2. Analysis

Comparison 2: Malaise, Outcome 2: Malaise severity on day 3: delayed versus immediate antibiotics

2.3

2.3. Analysis

Comparison 2: Malaise, Outcome 3: Duration of malaise: delayed versus immediate antibiotics

2.4

2.4. Analysis

Comparison 2: Malaise, Outcome 4: Duration of malaise: delayed versus no antibiotics

3.1

3.1. Analysis

Comparison 3: Fever, Outcome 1: Number of participants with fever on days 3 to 6: delayed (prescription at time of visit) versus immediate antibiotics

3.2

3.2. Analysis

Comparison 3: Fever, Outcome 2: Fever severity on day 3: delayed (prescription at time of visit) versus immediate antibiotic

3.3

3.3. Analysis

Comparison 3: Fever, Outcome 3: Duration of fever: delayed versus immediate antibiotics

3.4

3.4. Analysis

Comparison 3: Fever, Outcome 4: Duration of fever: delayed versus no antibiotics

4.1

4.1. Analysis

Comparison 4: Antibiotic use, Outcome 1: Antibiotic use: delayed versus immediate antibiotics

4.2

4.2. Analysis

Comparison 4: Antibiotic use, Outcome 2: Antibiotic use: delayed versus no antibiotics

5.1

5.1. Analysis

Comparison 5: Patient satisfaction, Outcome 1: Patient satisfaction: delayed versus immediate antibiotics

5.2

5.2. Analysis

Comparison 5: Patient satisfaction, Outcome 2: Patient satisfaction: delayed versus no antibiotics

6.1

6.1. Analysis

Comparison 6: Adverse events, Outcome 1: Vomiting: delayed versus immediate antibiotics

6.2

6.2. Analysis

Comparison 6: Adverse events, Outcome 2: Vomiting: delayed (prescription collection) versus no antibiotics

6.3

6.3. Analysis

Comparison 6: Adverse events, Outcome 3: Diarrhoea: delayed versus immediate antibiotics

6.4

6.4. Analysis

Comparison 6: Adverse events, Outcome 4: Diarrhoea: delayed (prescription collection) versus no antibiotics

6.5

6.5. Analysis

Comparison 6: Adverse events, Outcome 5: Rash: delayed (prescription collection) versus immediate antibiotics

6.6

6.6. Analysis

Comparison 6: Adverse events, Outcome 6: Rash: delayed (prescription collection) versus no antibiotics

7.1

7.1. Analysis

Comparison 7: Reconsultation rate, Outcome 1: Reconsultation rate: delayed versus immediate antibiotics

7.2

7.2. Analysis

Comparison 7: Reconsultation rate, Outcome 2: Reconsultation rate: delayed versus no antibiotics

Update of

Similar articles

Cited by

References

References to studies included in this review

Arroll 2002a {published and unpublished data}
    1. Arroll B, Kenealy T, Kerse N. Do delayed prescriptions reduce the use of antibiotics for the common cold? A single-blind controlled trial. Journal of Family Practice 2002;51(4):324-8. - PubMed
Chao 2008 {published data only (unpublished sought but not used)}
    1. Chao J, Kunkov S, Reyes L, Lichten S, Crain E. Comparison of two approaches to observation therapy for acute otitis media in the emergency department. Pediatrics 2008;121(5):1352-6. - PubMed
De la Poza Abad 2016 {published data only}
    1. De La Poza Abad M, Dalmau GM, Bakedano MM, Gonzalez AIG, Criado YC, Anadon SH, et al. Rationale, design and organization of the delayed antibiotic prescription (DAP) trial: a randomized controlled trial of the efficacy and safety of delayed antibiotic prescribing strategies in the non-complicated acute respiratory tract infections in general practice. BMC Family Practice 2013;14:Article No.63. [DOI: 10.1186/1471-2296-14-63] - DOI - PMC - PubMed
    1. De la Poza Abad M, Dalmau GM, Bakedano MM, González AI, Criado YC, Anadón SH, et al. Prescription strategies in acute uncomplicated respiratory infections. JAMA 2016;176(1):21-9. [DOI: 10.1001/jamainternmed.2015.7088] - DOI - PubMed
    1. EUCTR2011-005741-13-ES. Delayed antibiotic prescription for respiratory infections in children. www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:201... 12 December 2011.
    1. NCT01363531. Clinical trial for the assessment of delayed antibiotic treatment strategies in the non-complicated acute respiratory tract infections in General Practice. clinicaltrials.gov/show/NCT01363531 (first received 18 May 2011).
Dowell 2001 {published data only}
    1. Dowell J, Pitkethy M, Bain J, Martin S. A randomised controlled trial of delayed antibiotic prescribing as a strategy for managing uncomplicated respiratory tract infection in primary care. British Journal of General Practice 2001;51(464):200-5. - PMC - PubMed
El‐Daher 1991 {published data only}
    1. El-Daher N, Rawashedeh N, Al-Khalil I, Abu-ektaish F. Immediate versus delayed treatment of group A beta-haemolytic streptococcal pharyngitis with penicillin V. Pediatric Infectious Disease Journal 1991;10(2):126-30. - PubMed
Gerber 1990 {published data only}
    1. Gerber M, Randolph M, DeMeo K, Kaplan E. Lack of impact of early antibiotic therapy for streptococcal pharyngitis on recurrence rates. Journal of Pediatrics 1990;117(6):853-8. - PubMed
Little 1997 {published data only}
    1. Little P, Williamson I, Warner G, Gould C, Gantley M, Kinmonth AL. Open randomised trial of prescribing strategies in managing sore throat. BMJ 1997;314(7082):722-7. - PMC - PubMed
Little 2001 {published and unpublished data}
    1. Little P, Gould C, Williamson I, Moore M, Warner G, Dunleavey J. Pragmatic randomised controlled trial of two prescribing strategies for childhood acute otitis media. BMJ 2001;322(7282):336-42. - PMC - PubMed
    1. Little P, Moore M, Warner G, Dunleavy J, Williamson I. Longer term outcomes from a randomised trial of prescribing strategies in otitis media. British Journal of General Practice 2006;56(524):176-82. - PMC - PubMed
Little 2005a {published data only}
    1. ISRCTN92319172. Randomised controlled trial of a leaflet and three prescribing strategies for the management of acute lower respiratory tract illness. Acute Cough Trial. isrctn.com/ISRCTN92319172 (first received 23 October 2000).
    1. Little P, Rumsby K, Kelly J, Watson L, Moore M, Warner G, et al. Information leaflet and antibiotic prescribing strategies for acute lower respiratory infection. JAMA 2005;293(24):3029-35. - PubMed
    1. Moore M, Little P, Rumsby K, Kelly J, Watson L, Warner G, et al. Effect of antibiotic prescribing strategies and an information leaflet on longer-term reconsultation for acute lower respiratory tract infection. British Journal of General Practice 2009;59(567):728-34. - PMC - PubMed
Mas‐Dalmau 2021 {published data only (unpublished sought but not used)}
    1. Mas-Dalmau G, Villanueva López C, Gorrotxategi Gorrotxategi P, Argüelles Prendes E, Espinazo Ramos O, Valls Duran T, et al. Delayed antibiotic prescription for children with respiratory infections: a randomized trial. Pediatrics 2021;147(3):e20201323. - PubMed
Pichichero 1987 {published data only}
    1. Pichichero M, Disney F, Talpey W, Green J, Francis A, Roghmann K, et al. Adverse and beneficial effects of immediate treatment of group A beta-haemolytic streptococcal pharyngitis with penicillin. Pediatric Infectious Disease Journal 1987;6(7):635-43. - PubMed
Spiro 2006 {published data only}
    1. Spiro DM, Tay KY, Arnold DH, Dziura JD, Baker MD, Shapiro ED. Wait-and-see prescription for the treatment of acute otitis media: a randomized controlled trial. JAMA 2006;296(10):1235-41. - PubMed

References to studies excluded from this review

Agnew 2013 {published data only}
    1. Agnew J, Taaffe M, Darker C, O'Shea B, Clarke J. Delayed prescribing of antibiotics for respiratory tract infections: use of information leaflets. Irish Medical Journal 2013;106(8):243-4. - PubMed
Cates 1999 {published data only}
    1. Cates C. An evidence based approach to reducing antibiotics use in children with acute otitis media: controlled before and after study. BMJ 1999;318:715-6. - PMC - PubMed
De la Poza Abad 2013 {published data only}
    1. De la Poza Abad M, Mas Dalmau G, Moreno Bakedano M, González González AI, Canellas Criado Y, Hernández Anadón S, et al. Rationale, design and organization of the delayed antibiotic prescription (DAP) trial: a randomized controlled trial of the efficacy and safety of delayed antibiotic prescribing strategies in the non-complicated acute respiratory tract infections in general practice. BMC Family Practice 2013;14(63):1-7. [DOI: 10.1186/1471-2296-14-63] - DOI - PMC - PubMed
Fischer 2009 {published data only}
    1. Fischer T, Singer A, Chale S. Observation option for acute otitis media in the emergency department. Paediatric Emergency Care 2009;25(9):575-8. - PubMed
Ghebrehewet 2020 {published data only}
    1. Ghebrehewet S, Shepherd W, Panford-Quainoo E, Shantikumar S, Decraene V, Rajendran R, et al. Implementation of a delayed prescribing model to reduce antibiotic prescribing for suspected upper respiratory tract infections in a hospital outpatient department, Ghana. Antibiotics (Basel) 2020;9(773):1-11. - PMC - PubMed
Little 2014 {published data only}
    1. Little P, Moore M, Kelly J, Williamson I, Leydon G, McDermott L, et al. Delayed antibiotic prescribing strategies for respiratory tract infections in primary care: pragmatic, factorial, randomised controlled trial. BMJ 2014;348:g1606. [DOI: 10.1136/bmj.g1606] - DOI - PMC - PubMed
Newson 2009 {published data only}
    1. Newson L. Delayed prescribing. Practice Nurse 2009;37(2):21.
Siegel 2003 {published data only}
    1. Siegel R, Kiely M, Bien JP, Joseph EC, Davis JB, Mendel SG, et al. Treatment of otitis media with observation and a safety-net antibiotic prescription. Pediatrics 2003;112(3):527-31. - PubMed
Vouloumanou 2009 {published data only}
    1. Vouloumanou E, Karageorgopoulos D, Kazanti M, Kapaskelis A, Falagas M. Antibiotics versus placebo or watchful waiting for acute otitis media: a meta-analysis of randomized controlled trials. Journal of Antimicrobial Chemotherapy 2009;64(1):16-24. - PubMed
Worrall 2010 {published data only}
    1. NCT02732847. Trial of post-dated delayed antibiotic prescriptions [Post-dated versus voluntary delayed antibiotic prescriptions for acute respiratory infections in primary care: a randomized trial]. clinicaltrials.gov/show/NCT02732847 (first received 27 May 2010).
    1. Worrall G, Kettle A, Graham W, Hutchinson J. Postdated versus usual delayed antibiotic prescriptions in primary care: reduction in antibiotic use for acute respiratory infections? Canadian Family Physician 2010;56(10):1032-6. - PMC - PubMed

Additional references

AHRQ 2016
    1. Agency for Healthcare Research and Quality. Improving antibiotic prescribing for uncomplicated acute respiratory tract infections. Rockville (MD): AHRQ; 2016. Comparative Effectiveness Review No. 163. - PubMed
Arroll 2002b
    1. Arroll B, Goodyear-Smith F, Thomas D, Kerse N. Delayed antibiotic prescriptions: what are the experiences and attitudes of physicians and patients? Journal of Family Practice 2002;51(11):954-9. - PubMed
Arroll 2003a
    1. Arroll B, Kenealy T, Kerse N. Do delayed prescriptions reduce antibiotic use in respiratory tract infections? A systematic review. British Journal of General Practice 2003;53:871-7. - PMC - PubMed
Arroll 2003b
    1. Arroll B, Kenealy T, Goodyear-Smith F, Kerse N. Delayed prescriptions. BMJ 2003;327(7428):1361-2. - PMC - PubMed
Arroll 2013
    1. Arroll B, Kenealy T. Antibiotics for the common cold and acute purulent rhinitis. Cochrane Database of Systematic Reviews 2013, Issue 6. Art. No: CD000247. [DOI: 10.1002/14651858.CD000247.pub3] - DOI - PMC - PubMed
Atkins 2004
    1. Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, et al, GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ 2004;328(7454):1490-4. - PMC - PubMed
Butler 2001
    1. Butler CC, Kinnersley P, Prout H, Rollnick S, Edwards A, Elwyn G. Antibiotics and shared decision-making in primary care. Journal of Antimicrobial Chemotherapy 2001;48(3):435-40. - PubMed
CDC 2022
    1. Centers for Disease Control and Prevention. About Antimicrobial Resistance. https://www.cdc.gov/drugresistance/about.html Last reviewed 5 October 2022 (accessed prior to 29 August 2017).
Datta 2008
    1. Datta M. Review: delayed or immediate prescriptions of antibiotics have similar clinical outcomes in respiratory infections. Evidence-Based Medicine 2008;13(2):42. - PubMed
Everitt 2006
    1. Everitt H, Little P, Smith P. A randomised controlled trial of management strategies for acute infective conjunctivitis in general practice. BMJ 2006;333(7563):321. - PMC - PubMed
French 1950
    1. French JR. Field experiments: changing group productivity. In: Miller JG, editors(s). Experiments in Social Process: a Symposium on Social Psychology. McGraw-Hill, 1950:82.
Goossens 2005
    1. Goossens H, Ferech M, Vander Stichele R, Elseviers M. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005;365(9459):579-87. - PubMed
GRADEpro GDT [Computer program]
    1. GRADEpro GDT. Version accessed 15 April 2017. Hamilton (ON): McMaster University (developed by Evidence Prime). Available at gradepro.org.
Higgins 2011
    1. Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.
Hoffmann 2017
    1. Hoffmann T, Oxman A, Ioannidis J, Moher D, Lasserson T, Tovey D, et al. Enhancing the usability of systematic reviews by improving the consideration and description of interventions. BMJ 2017;358:j2998. - PubMed
Johnson 2007
    1. Johnson NC, Holger JS. Pediatric acute otitis media: the case for delayed antibiotic treatment. Journal of Emergency Medicine 2007;32(3):279-84. - PubMed
Kempf 2016
    1. Kempf I, Jouy E, Chauvin C. Colistin use and colistin resistance in bacteria from animals. International Journal of Antimicrobial Agents 2016;48:598-606. - PubMed
Kenealy 2013
    1. Kenealy T, Arroll B. Antibiotics for the common cold and acute purulent rhinitis. Cochrane Database of Systematic Reviews 2013, Issue 6. Art. No: CD000247. [DOI: 10.1002/14651858.CD000247.pub3] - DOI - PMC - PubMed
Kumar 2003
    1. Kumar S, Little P, Britten N. Why do general practitioners prescribe antibiotics for sore throat? BMJ 2003;326(7392):138-43. - PMC - PubMed
Legare 2007
    1. Legare F, Labrecque M, Leblanc A, Thivierge R, Godin G, Laurier C, et al. Does training family physicians in shared decision making promote optimal use of antibiotics for acute respiratory infections? Study protocol of a pilot clustered randomised controlled trial. BMC Family Practice 2007;8:65. - PMC - PubMed
Levitt 2011
    1. Levitt SD, List JA. Was there really a Hawthorne effect at the Hawthorne plant? An analysis of the original illumination experiments. American Economic Journal: Applied Economics 2011;3(1):224-38.
Little 2005b
    1. Little P. Delayed prescribing of antibiotics for upper respiratory tract infection. BMJ 2005;331(7512):301-2. - PMC - PubMed
Little 2006
    1. Little P, Moore M, Warner G, Dunleavy J, Williamson I. Longer term outcomes from a randomised trial of prescribing strategies in otitis media. British Journal of General Practice 2006;56(524):176-82. - PMC - PubMed
Little 2014
    1. Little P, Moore M, Kelly J, Williamson I, Leydon G, McDermott L, et al, Pips Investigators. Delayed antibiotic prescribing strategies for respiratory tract infections in primary care: pragmatic, factorial, randomised controlled trial. BMJ 2014;348:g1606. - PMC - PubMed
Little 2017
    1. Little P, Stuart B, Smith S, Thompson MJ, Knox K, den Bruel A, et al. Antibiotic prescription strategies and adverse outcome for uncomplicated lower respiratory tract infections: prospective cough complication cohort (3C) study. BMJ 2017;357:j2418. - PMC - PubMed
Llor 2014
    1. Llor C, Bjerrum L. Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem. Therapeutic Advances in Drug Safety 2014;5:229-41. - PMC - PubMed
Macfarlane 1997
    1. Macfarlane J, Holmes W, Macfarlane R, Britten N. Influence of patient's expectations on antibiotic management of acute lower respiratory tract illness in general practice: questionnaire study. BMJ 1997;315:1211-4. - PMC - PubMed
McDonagh 2018
    1. McDonagh M, Peterson K, Winthrop K, Cantor A, Lazur B, Buckley D. Interventions to reduce inappropriate prescribing of antibiotics for acute respiratory tract infections: summary and update of a systematic review. Journal of International Medical Research 2018;46:3337-57. [DOI: 10.1177/0300060518782519] - DOI - PMC - PubMed
Moher 2009
    1. Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA Statement. BMJ 2009;339:2535. - PMC - PubMed
Moore 2009
    1. Moore M, Little P, Rumsby K, Kelly J, Watson L, Warner G, et al. Effect of antibiotic prescribing strategies and an information leaflet on longer-term reconsultation for acute lower respiratory tract infection. British Journal of General Practice 2009;59(567):728-34. - PMC - PubMed
NICE 2016
    1. National Institute for Health and Care. Quality statement 2: Back-up (delayed) prescribing. nice.org.uk/guidance/qs121/chapter/Quality-statement-2-Back-up-delayed-p... 2016.
OMTG 2004
    1. Otitis Media Treatment Guidelines. Diagnosis and management of acute otitis media. Pediatrics 2004;113(5):1451-65. - PubMed
RevMan Web 2019 [Computer program]
    1. Review Manager Web (RevMan Web). The Cochrane Collaboration, 2019. Available at revman.cochrane.org.
Sharland 2005
    1. Sharland M, Kendall H, Yeates D, Randall A, Hughes G, Glasziou P, et al. Antibiotic prescribing in general practice and hospital admissions for peritonsillar abscess, mastoiditis and rheumatic fever in children: time trend analysis. BMJ 2005;331(7512):328-9. - PMC - PubMed
Smith 2014
    1. Smith SM, Fahey T, Smucny J, Becker LA. Antibiotics for acute bronchitis. Cochrane Database of Systematic Reviews 2014, Issue 3. Art. No: CD000245. [DOI: 10.1002/14651858.CD000245.pub2] - DOI - PubMed
Spinks 2013
    1. Spinks A, Glasziou PP, Del Mar C. Antibiotics for sore throat. Cochrane Database of Systematic Reviews 2013, Issue 11. Art. No: CD000023. [DOI: 10.1002/14651858.CD000023.pub3] - DOI - PMC - PubMed
Sun 2012
    1. Sun L, Klein E, Laxminarayan R. Seasonality and temporal correlation between community antibiotic use and resistance in the United States. Clinical Infectious Diseases 2012;55:687-94. - PubMed
Sung 2006
    1. Sung L, Arroll J, Arroll B, Goodyear-Smith F, Kerse N, Norris P. Antibiotic use for upper respiratory tract infections before and after an education campaign as reported by general practitioners in New Zealand. New Zealand Medical Journal 2006;119(1233):U1956. - PubMed
Tan 2008
    1. Tan T, Little P, Stokes T. Antibiotic prescribing for self limiting respiratory tract infections in primary care: summary of NICE guidance. BMJ 2008;337:a437. - PubMed
van Staa 2021
    1. Staa TP, Palin V, Brown B, Welfare W, Li Y, Ashcroft DM. The safety of delayed versus immediate antibiotic prescribing for upper respiratory tract infections. Clinical Infectious Diseases 2021;73(2):e394-e401. [DOI: 10.1093/cid/ciaa890] - DOI - PMC - PubMed
Van Zuijlen 2001
    1. Van Zuijlen DA, Schilder AG, Van Balen FA, Hoes AQ. National differences in incidences of acute mastoiditis: relationship to prescribing patterns for acute otitis media. Pediatric Infectious Disease 2001;20:140-4. - PubMed
Venekamp 2015
    1. Venekamp RP, Sanders S, Glasziou PP, Del Mar CB, Rovers MM. Antibiotics for acute otitis media in children. Cochrane Database of Systematic Reviews 2015, Issue 6. Art. No: CD000219. [DOI: 10.1002/14651858.CD000219.pub3] - DOI - PubMed
WHO 2014
    1. World Health Organization. Antimicrobial resistance: Global report on surveillance 2014. Geneva: WHO; 2014.
World Bank 2017
    1. World Bank. World Bank country and lending groups. World Bank (available at https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-b...) 2017.

References to other published versions of this review

Spurling 2003
    1. Spurling GKP, Del Mar CB. Delayed antibiotics for respiratory infections. Cochrane Database of Systematic Reviews 2003, Issue 4. Art. No: CD004417. [DOI: 10.1002/14651858.CD004417] - DOI - PubMed
Spurling 2007
    1. Spurling GKP, Del Mar CB, Dooley L, Foxlee R. Delayed antibiotics for symptoms and complications of respiratory infections. Cochrane Database of Systematic Reviews 2007, Issue 2. Art. No: CD004417. [DOI: 10.1002/14651858.CD004417.pub2] - DOI - PubMed
Spurling 2010
    1. Spurling GKP, Del Mar CB, Dooley L, Foxlee R. Delayed antibiotics for respiratory infections. Cochrane Database of Systematic Reviews 2010, Issue 1. Art. No: CD004417. [DOI: 10.1002/14651858.CD004417.pub2] - DOI - PubMed
Spurling 2013
    1. Spurling GKP, Del Mar CB, Dooley L, Foxlee R, Farley R. Delayed antibiotics for respiratory infections. Cochrane Database of Systematic Reviews 2013, Issue 4. Art. No: CD004417. [DOI: 10.1002/14651858.CD004417.pub4] - DOI - PubMed
Spurling 2017
    1. Spurling GKP, Del Mar CB, Dooley L, Foxlee R, Farley R. Delayed antibiotic prescriptions for respiratory infections. Cochrane Database of Systematic Reviews 2017, Issue 9(9):CD004417.doi: 10.1002/14651858.CD004417.pub5.. Art. No: CD004417. [DOI: 10.1002/14651858.CD004417.pub5] - DOI - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources